Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:    
Net loss $ (7,166,667) $ (1,711,849)
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on sale of securities 36,714 4,258
Accrued (income)/loss on marketable securities 348 3,514
Depreciation and amortization 27,712 34,979
Impairment of Prepaid Royalties 291,442
Impairment of Production Equipment 18,680
Impairment of intangible assets 152,822
Inventory adjustment for net realizable value 197,723
Reserve for doubtful trade receivables 1,273 4,247
Share based compensation to an employee - common stock 22,444
Share based compensation to directors - restricted stock units 1,302 122,384
Share based compensation - shares issued to vendors 7,318
Shares issued for the purchase of a license 1,233,057
Change in assets and liabilities    
(Increase)/Decrease in trade receivables 63,548 (94,781)
Decrease in deposits and other receivables 9,347
Decrease in inventories 1,262 41,026
Decrease in prepaid expenses 176,001 305,531
Decrease in other assets 2,722 4,330
(Increase)/Decrease in trade and other payables 1,071,566 (355,782)
Increase in operating lease liability 76
Net cash used by operating activities (3,883,101) (1,610,352)
Cash flows from investing activities:    
Purchases of marketable securities (76,095) (62,516)
Proceeds from sale of marketable securities 2,307,462 1,354,646
Net cash provided by investing activities 2,231,367 1,292,130
Cash flows from financing activities    
Net proceeds from issuance of common stock 8,406,927
Net proceeds from the exercise of Series C Convertible Preferred warrants and conversion into common stock 4,174,000
Net proceeds from the exercise of prepaid equity forward contracts for the purchase of common stock 80
Net cash provided by financing activities 12,581,007
Net increase/(decrease) in cash and restricted cash 10,929,273 (318,222)
Cash and restricted cash at beginning of period 632,538 681,755
Cash and restricted cash at end of period 11,561,811 363,533
Cash paid for:    
Interest
Income Taxes
Supplemental Schedule of Non-Cash Financing and Investing Activities    
Net unrealized gains/(losses) on marketable securities (39,039) 47,402
Operating lease right-of-use asset obtained in exchange for lease obligation $ (79,942)